Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up

Overview of attention for article published in Drug Design, Development and Therapy, July 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 60 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

Efficacy and Safety of Inclisiran, Alirocumab, Evolocumab, and Evinacumab in Lipid-Lowering: A Network Meta-Analysis

Preprint in Research Square (April 2024)

Retrospective study on clinical efficacy of Evolocumab in highrisk ASCVD patients

Article in Pharmacy Practice (June 2023)

The First Report of a Real-world Experience With a PCSK9 Inhibitor in a Large Familial Hyperlipidemia and Very-high-risk Middle Eastern Population

Article in Clinical Therapeutics (September 2022)